A novel small-molecule inhibitor of HIV-1 entry

Por Heredia, Alonso, Latinovic, Olga S, Barbault, Florent, de Leeuw, Erik PH
Publicado no Drug Des Devel Ther (2015)

Striking HIV-1 Entry by Targeting HIV-1 gp41. But, Where Should We Target?

Por Teixeira, Cátia, Barbault, Florent, Couesnon, Thierry, Gomes, José R. B., Gomes, Paula, Maurel, François
Publicado no PLoS One (2016)

Lead optimization of antifungal peptides with 3D NMR structures analysis

Por Landon, Céline, Barbault, Florent, Legrain, Michèle, Menin, Laure, Guenneugues, Marc, Schott, Valérie, Vovelle, Françoise, Dimarcq, Jean-Luc
Publicado em 2004

Design, Synthesis, and Biological Evaluation of N-Carboxyphenylpyrrole Derivatives as Potent HIV Fusion Inhibitors Targeting gp41

Por Liu, Kun, Lu, Hong, Hou, Ling, Qi, Zhi, Teixeira, Cátia, Barbault, Florent, Fan, Bo-Tao, Liu, Shuwen, Jiang, Shibo, Xie, Lan
Publicado em 2008

Diarylaniline Derivatives as a Distinct Class of HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors

Por Qin, Bingjie, Jiang, Xingkai, Lu, Hong, Tian, Xingtao, Barbault, Florent, Huang, Li, Qian, Keduo, Chen, Chin-Ho, Huang, Rong, Jiang, Shibo, Lee, Kuo-Hsiung, Xie, Lan
Publicado em 2010

Tyrosine kinase inhibitor NVP-BGJ398 functionally improves FGFR3-related dwarfism in mouse model

Por Komla-Ebri, Davide, Dambroise, Emilie, Kramer, Ina, Benoist-Lasselin, Catherine, Kaci, Nabil, Le Gall, Cindy, Martin, Ludovic, Busca, Patricia, Barbault, Florent, Graus-Porta, Diana, Munnich, Arnold, Kneissel, Michaela, Di Rocco, Federico, Biosse-Duplan, Martin, Legeai-Mallet, Laurence
Publicado no J Clin Invest (2016)